Literature DB >> 24131693

Development of a capillary electrophoresis-based heteroduplex tracking assay to measure in-host genetic diversity of initial and recurrent Plasmodium vivax infections in Cambodia.

Matthew B Givens1, Jessica T Lin, Chanthap Lon, Panita Gosi, Meng Chuor Char, Charlotte A Lanteri, David L Saunders, Jonathan J Juliano.   

Abstract

A heteroduplex tracking assay used to genotype Plasmodium vivax merozoite surface protein 1 was adapted to a capillary electrophoresis format, obviating the need for radiolabeled probes and allowing its use in settings where malaria is endemic. This new assay achieved good allelic discrimination and detected high multiplicities of infection in 63 P. vivax infections in Cambodia. More than half of the recurrent parasitemias sampled displayed identical or highly related genotypes compared to the initial genotype, suggesting that they represented relapses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24131693      PMCID: PMC3911425          DOI: 10.1128/JCM.02274-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Molecular markers and genetic diversity of Plasmodium vivax.

Authors:  Cristiana Ferreira Alves de Brito; Marcelo Urbano Ferreira
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

2.  Individual Plasmodium vivax msp1 variants within polyclonal P. vivax infections display different propensities for relapse.

Authors:  Jessica T Lin; Jonathan J Juliano; Oksana Kharabora; Rithy Sem; Feng-Chang Lin; Sinuon Muth; Didier Ménard; Chansuda Wongsrichanalai; William O Rogers; Steven R Meshnick
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

3.  Evaluation of Plasmodium vivax genotyping markers for molecular monitoring in clinical trials.

Authors:  Cristian Koepfli; Ivo Mueller; Jutta Marfurt; Mary Goroti; Albert Sie; Olive Oa; Blaise Genton; Hans-Peter Beck; Ingrid Felger
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

4.  Plasmodium vivax isolates from Cambodia and Thailand show high genetic complexity and distinct patterns of P. vivax multidrug resistance gene 1 (pvmdr1) polymorphisms.

Authors:  Jessica T Lin; Jaymin C Patel; Oksana Kharabora; Jetsumon Sattabongkot; Sinuon Muth; Ratawan Ubalee; Anthony L Schuster; William O Rogers; Chansuda Wongsrichanalai; Jonathan J Juliano
Journal:  Am J Trop Med Hyg       Date:  2013-03-18       Impact factor: 2.345

5.  Contrasting genetic structure in Plasmodium vivax populations from Asia and South America.

Authors:  Mallika Imwong; Shalini Nair; Sasithon Pukrittayakamee; Daniel Sudimack; Jeff T Williams; Mayfong Mayxay; Paul N Newton; Jung Ryong Kim; Amitab Nandy; Lyda Osorio; Jane M Carlton; Nicholas J White; Nicholas P J Day; Tim J C Anderson
Journal:  Int J Parasitol       Date:  2007-03-12       Impact factor: 3.981

6.  Control and elimination of Plasmodium vivax.

Authors:  G Dennis Shanks
Journal:  Adv Parasitol       Date:  2012       Impact factor: 3.870

7.  A long neglected world malaria map: Plasmodium vivax endemicity in 2010.

Authors:  Peter W Gething; Iqbal R F Elyazar; Catherine L Moyes; David L Smith; Katherine E Battle; Carlos A Guerra; Anand P Patil; Andrew J Tatem; Rosalind E Howes; Monica F Myers; Dylan B George; Peter Horby; Heiman F L Wertheim; Ric N Price; Ivo Müeller; J Kevin Baird; Simon I Hay
Journal:  PLoS Negl Trop Dis       Date:  2012-09-06

Review 8.  Determinants of relapse periodicity in Plasmodium vivax malaria.

Authors:  Nicholas J White
Journal:  Malar J       Date:  2011-10-11       Impact factor: 2.979

9.  Multiplicity and diversity of Plasmodium vivax infections in a highly endemic region in Papua New Guinea.

Authors:  Cristian Koepfli; Amanda Ross; Benson Kiniboro; Thomas A Smith; Peter A Zimmerman; Peter Siba; Ivo Mueller; Ingrid Felger
Journal:  PLoS Negl Trop Dis       Date:  2011-12-20

10.  Multiple-clone activation of hypnozoites is the leading cause of relapse in Plasmodium vivax infection.

Authors:  Flávia Carolina F de Araujo; Antônio Mauro de Rezende; Cor Jesus F Fontes; Luzia Helena Carvalho; Cristiana F Alves de Brito
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more
  5 in total

1.  Using Amplicon Deep Sequencing to Detect Genetic Signatures of Plasmodium vivax Relapse.

Authors:  Jessica T Lin; Nicholas J Hathaway; David L Saunders; Chanthap Lon; Sujata Balasubramanian; Oksana Kharabora; Panita Gosi; Sabaithip Sriwichai; Laurel Kartchner; Char Meng Chuor; Prom Satharath; Charlotte Lanteri; Jeffrey A Bailey; Jonathan J Juliano
Journal:  J Infect Dis       Date:  2015-03-06       Impact factor: 5.226

2.  Classification of disease recurrence using transition likelihoods with expectation-maximization algorithm.

Authors:  Huijun Jiang; Quefeng Li; Jessica T Lin; Feng-Chang Lin
Journal:  Stat Med       Date:  2022-07-31       Impact factor: 2.497

3.  Genotyping of Plasmodium vivax by minisatellite marker and its application in differentiating relapse and new infection.

Authors:  Ram Das; Ramesh C Dhiman; Deepali Savargaonkar; Anupkumar R Anvikar; Neena Valecha
Journal:  Malar J       Date:  2016-02-24       Impact factor: 2.979

4.  Differing patterns of selection and geospatial genetic diversity within two leading Plasmodium vivax candidate vaccine antigens.

Authors:  Christian M Parobek; Jeffrey A Bailey; Nicholas J Hathaway; Duong Socheat; William O Rogers; Jonathan J Juliano
Journal:  PLoS Negl Trop Dis       Date:  2014-04-17

5.  Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia.

Authors:  Suwanna Chaorattanakawee; Chanthap Lon; Soklyda Chann; Kheang Heng Thay; Nareth Kong; Yom You; Siratchana Sundrakes; Chatchadaporn Thamnurak; Sorayut Chattrakarn; Chantida Praditpol; Kritsanai Yingyuen; Mariusz Wojnarski; Rekol Huy; Michele D Spring; Douglas S Walsh; Jaymin C Patel; Jessica Lin; Jonathan J Juliano; Charlotte A Lanteri; David L Saunders
Journal:  Malar J       Date:  2017-09-30       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.